In this webinar, the evolving role of radiation treatment in metastatic and primary site radiation for musculoskeletal tumors will be discussed. We will focus on the emergence of stereotactic body radiation (SBRT) as a standard approach particularly in metastatic disease and review current data in both the adult and pediatric settings. The future potential indications of SBRT and hypofractionated approaches for this patient population will also be addressed.
